Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases-Reference-Cited by-同舟云学术

Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases

Published:2020-08-31 Issue:37 Volume:59 Page:3447-3462
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Hewitt Chad S.¹^ORCID,Krabill Aaron D.¹^ORCID,Das Chittaranjan²³^ORCID,Flaherty Daniel P.¹³⁴^ORCID

Affiliation:

1. Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana 47907, United States

2. Department of Chemistry, College of Science, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, United States

3. Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States

4. Purdue Institute for Drug Discovery, Purdue University, West Lafayette, Indiana 47907, United States

Funder

Purdue Medicinal Chemistry and Molecular Pharmacology, Purdue University

Purdue Institute for Drug Discovery, Purdue University

College of Pharmacy, Purdue University

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.biochem.9b01076

Reference63 articles.

1. Dynamic ubiquitin signaling in cell cycle regulation

2. Ubiquitin chain diversity at a glance

3. DUBs, the regulation of cell identity and disease

4. Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses

5. Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1;Journal of Medicinal Chemistry;2024-03-15

2. Identification of covalent fragment inhibitors for Plasmodium falciparum UCHL3 with anti-malarial efficacy;Bioorganic & Medicinal Chemistry Letters;2023-10

3. Ubiquitin Engineering for Interrogating the Ubiquitin–Proteasome System and Novel Therapeutic Strategies;Cells;2023-08-21

4. Robust Design of Effective Allosteric Activators for Rsp5 E3 Ligase Using the Machine Learning Tool ProteinMPNN;ACS Synthetic Biology;2023-08-09

5. Imaging of proteases using activity-based probes;Current Opinion in Chemical Biology;2023-06